Human Papilloma Virus (HPV) Completed Phase 2 Trials for Human papillomavirus type 18 L1 capsid protein antigen (DB10302)
Also known as: Human Papilloma Virus / HPV Infections / HPV (Human Papillomavirus) / Human Papillomavirus (HPV) / HPV Infection / Human Papillomavirus / HPV Disease / Papilloma Virus, Human / Human Papillomavirus Infection / Human papillomavirus infection (disorder) / Human papilloma virus infection / Human Papillomavirus Viruses / Human papillomavirus (organism) / Papillomavirus Infections / Disease caused by Papillomavirus (disorder) / Papilloma viral infection / Papilloma viral infection NOS / Papilloma viral infections
| Indication | Status | Phase |
|---|---|---|
| DBCOND0040889 (Human Papilloma Virus (HPV)) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00411749 | V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028) | Prevention | |
| NCT00378560 | V501 Efficacy Study in Women Aged 18 to 26 (V501-027) | Prevention | |
| NCT04436133 | Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) | Prevention |
|
| NCT01432574 | Study of Gardasil in Mid-Adult Males (MAM) | Prevention |